{
    "title": "109_s2255",
    "content": "The Act titled \"Medicare Drug Formulary Protection Act\" allows for the removal of covered Part D drugs from the prescription drug plan formulary. The Medicare Drug Formulary Protection Act prohibits the removal or restriction of covered Part D drugs from the prescription drug plan formulary starting in 2006. The Medicare Drug Formulary Protection Act prohibits changes to drug coverage in prescription drug plans, except for new therapeutic uses and newly covered drugs. Newly enrolled individuals are also protected from drug removal or restrictions. The Medicare Drug Formulary Protection Act prohibits PDP sponsors from removing covered Part D drugs or imposing restrictions on coverage for newly enrolled individuals, except for new therapeutic uses and newly covered drugs. The Medicare Drug Formulary Protection Act prohibits PDP sponsors from removing covered Part D drugs or imposing restrictions on coverage for newly enrolled individuals, except for new therapeutic uses and newly covered drugs, with specific exceptions for brand name drugs with generic alternatives, drugs going off-patent, and drugs approved by the Commissioner of Food and Drugs. The Medicare Drug Formulary Protection Act prohibits PDP sponsors from removing covered Part D drugs or imposing restrictions on coverage for newly enrolled individuals, except for specific exceptions like brand name drugs going off-patent, drugs with clinical warnings, or drugs determined to be ineffective. PDP sponsors must provide notice of any removal or change to the Secretary, affected enrollees, physicians, pharmacies, and pharmacists. The Medicare Drug Formulary Protection Act requires PDP sponsors to notify enrollees of any changes in formulary or coverage restrictions annually during the coordinated election period."
}